A-seeds
Blood & Organ Banks · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L 3/62 Lygon St Se 1, Carlton, Victoria,...Website
www.a-seeds.co.jpRevenue
<$5 MillionIndustry
About A-seeds
A-SEEDS is a venture company originating from Shinshu University, focused on the practical application of non-viral genetically modified immune cell therapy. The company aims to provide effective treatments for cancer patients, particularly in areas where treatment options are limited. Established around 2020, A-SEEDS is dedicated to overcoming the challenges of bringing innovative therapies from academia to clinical implementation. Their mission is to deliver hope to patients by making their long-developed therapies available as quickly as possible.Explore more
SIC Code 28,283NAICS Code 32,325Show more
A-seeds Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
A-seeds Tech Stack
A closer look at the technologies used by A-seeds
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding A-seeds
Sign Up For FreeTo access detailed company insights
A-SEEDS is a venture company originating from Shinshu University, focused on the practical application of non-viral genetically modified immune cell therapy. The company aims to provide effective treatments for cancer patients, particularly in areas where treatment options are limited. Established around 2020, A-SEEDS is dedicated to overcoming the... Read More
